WO2023026067 - LYOTROPIC LIQUID CRYSTALLINE NANOSYSTEMS WITH ENCAPSULATED BIOACTIVE MACROMOLECULES
National phase entry:
Publication Number
WO/2023/026067
Publication Date
02.03.2023
International Application No.
PCT/GR2022/000040
International Filing Date
29.07.2022
Title **
[English]
LYOTROPIC LIQUID CRYSTALLINE NANOSYSTEMS WITH ENCAPSULATED BIOACTIVE MACROMOLECULES
[French]
NANOSYSTÈMES LIQUIDES CRISTALLINS LYOTROPES AVEC MACROMOLÉCULES BIOACTIVES ENCAPSULÉES
Applicants **
UNI-PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES S.A.
14th km National Road 1
Kifisia, Attica
14564 Athens, GR
Inventors
DEMETZOS, Constantinos
523 Gr. Lampraki Ave
Keratsini
18757 Piraeus, GR
PISPAS, Asterios
19 Koletti Str
Ilion
13123 Athens, GR
CHOUNTOULESI, Maria
0 Feidonos & ext. Hatzi
21200 Argos, GR
Priority Data
20210100567
23.08.2021
GR
20220100481
08.06.2022
GR
20220100584
21.07.2022
GR
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter II
* |
| * | |
| * | |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1081 | |
| EPO | Filing, Examination | 4601 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 640 | |
| USA | Filing, Examination | 2710 |
Total: 9623 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
OH, wherein 2≤a≤150 and 15≤b≤70, and a bioactive macromolecule having peptide bonds.[French]
OH, où 2 ≤ a ≤ 150 et 15 ≤ b ≤ 70, et une macromolécule bioactive à liaisons peptidiques.